JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.58 Billion JPY | -21.72% |
| 2022 | 5.85 Billion JPY | 20.07% |
| 2021 | 4.87 Billion JPY | 6.3% |
| 2020 | 4.58 Billion JPY | -15.79% |
| 2019 | 5.44 Billion JPY | 8.88% |
| 2018 | 5 Billion JPY | 10.99% |
| 2017 | 4.5 Billion JPY | 3.49% |
| 2016 | 4.35 Billion JPY | 10.76% |
| 2015 | 3.93 Billion JPY | 31.69% |
| 2014 | 2.98 Billion JPY | -25.88% |
| 2013 | 4.02 Billion JPY | 80.01% |
| 2012 | 2.23 Billion JPY | 121.36% |
| 2011 | 1.01 Billion JPY | 83.91% |
| 2010 | 549.59 Million JPY | -8.01% |
| 2009 | 597.46 Million JPY | -5.6% |
| 2008 | 632.88 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 5.29 Billion JPY | 15.5% |
| 2024 Q3 | 5.61 Billion JPY | 0.41% |
| 2024 Q2 | 5.58 Billion JPY | 5.59% |
| 2023 Q2 | 6.92 Billion JPY | -3.15% |
| 2023 Q3 | 6.58 Billion JPY | -4.85% |
| 2023 Q4 | 4.58 Billion JPY | -30.43% |
| 2023 FY | 4.58 Billion JPY | -21.72% |
| 2023 Q1 | 7.14 Billion JPY | 22.11% |
| 2022 Q4 | 5.85 Billion JPY | 7.4% |
| 2022 FY | 5.85 Billion JPY | 20.07% |
| 2022 Q1 | 4.96 Billion JPY | 1.95% |
| 2022 Q3 | 5.44 Billion JPY | 12.0% |
| 2022 Q2 | 4.86 Billion JPY | -2.09% |
| 2021 Q3 | 5.59 Billion JPY | -0.14% |
| 2021 Q4 | 4.87 Billion JPY | -12.82% |
| 2021 Q1 | 5.42 Billion JPY | 18.28% |
| 2021 FY | 4.87 Billion JPY | 6.3% |
| 2021 Q2 | 5.59 Billion JPY | 3.25% |
| 2020 FY | 4.58 Billion JPY | -15.79% |
| 2020 Q1 | 5.38 Billion JPY | -1.14% |
| 2020 Q4 | 4.58 Billion JPY | -12.35% |
| 2020 Q3 | 5.23 Billion JPY | 9.92% |
| 2020 Q2 | 4.75 Billion JPY | -11.59% |
| 2019 Q2 | 6.01 Billion JPY | 1.18% |
| 2019 Q3 | 6.07 Billion JPY | 1.0% |
| 2019 Q4 | 5.44 Billion JPY | -10.39% |
| 2019 Q1 | 5.94 Billion JPY | 18.9% |
| 2019 FY | 5.44 Billion JPY | 8.88% |
| 2018 FY | 5 Billion JPY | 10.99% |
| 2018 Q2 | 5.66 Billion JPY | 1.09% |
| 2018 Q3 | 5.5 Billion JPY | -2.82% |
| 2018 Q4 | 5 Billion JPY | -9.17% |
| 2018 Q1 | 5.6 Billion JPY | 24.39% |
| 2017 Q4 | 4.5 Billion JPY | -6.88% |
| 2017 Q1 | 4.62 Billion JPY | 6.32% |
| 2017 Q2 | 4.59 Billion JPY | -0.69% |
| 2017 Q3 | 4.83 Billion JPY | 5.26% |
| 2017 FY | 4.5 Billion JPY | 3.49% |
| 2016 FY | 4.35 Billion JPY | 10.76% |
| 2016 Q4 | 4.35 Billion JPY | -18.81% |
| 2016 Q3 | 5.36 Billion JPY | -4.2% |
| 2016 Q2 | 5.59 Billion JPY | 8.17% |
| 2016 Q1 | 5.17 Billion JPY | 31.64% |
| 2015 Q1 | 3.36 Billion JPY | 12.63% |
| 2015 FY | 3.93 Billion JPY | 31.69% |
| 2015 Q2 | 3.26 Billion JPY | -2.8% |
| 2015 Q3 | 3.79 Billion JPY | 16.02% |
| 2015 Q4 | 3.93 Billion JPY | 3.68% |
| 2014 Q4 | 2.98 Billion JPY | -30.4% |
| 2014 FY | 2.98 Billion JPY | -25.88% |
| 2014 Q3 | 4.28 Billion JPY | -5.92% |
| 2014 Q2 | 4.55 Billion JPY | -1.33% |
| 2014 Q1 | 4.62 Billion JPY | 14.74% |
| 2013 Q2 | 2.91 Billion JPY | 19.39% |
| 2013 Q3 | 3.26 Billion JPY | 11.98% |
| 2013 Q4 | 4.02 Billion JPY | 23.31% |
| 2013 Q1 | 2.44 Billion JPY | 9.18% |
| 2013 FY | 4.02 Billion JPY | 80.01% |
| 2012 Q4 | 2.23 Billion JPY | 3.96% |
| 2012 Q2 | 1.5 Billion JPY | 14.21% |
| 2012 Q1 | 1.31 Billion JPY | 30.57% |
| 2012 Q3 | 2.15 Billion JPY | 42.78% |
| 2012 FY | 2.23 Billion JPY | 121.36% |
| 2011 FY | 1.01 Billion JPY | 83.91% |
| 2011 Q3 | 924.73 Million JPY | 14.61% |
| 2011 Q4 | 1.01 Billion JPY | 9.3% |
| 2011 Q1 | 760.79 Million JPY | 38.43% |
| 2011 Q2 | 806.87 Million JPY | 6.06% |
| 2010 FY | 549.59 Million JPY | -8.01% |
| 2010 Q4 | 549.59 Million JPY | -5.96% |
| 2010 Q3 | 584.45 Million JPY | 0.0% |
| 2009 Q4 | 597.46 Million JPY | 0.0% |
| 2009 Q1 | 695.6 Million JPY | 0.0% |
| 2009 Q2 | 591.23 Million JPY | -15.0% |
| 2009 FY | 597.46 Million JPY | -5.6% |
| 2008 FY | 632.88 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -3422924.905% |
| Ansell Limited | 457.04 Million USD | -902.313% |
| Ansell Limited | 457.9 Million USD | -900.437% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -10470.977% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -16425142.022% |
| Psykey, Inc. | 49.94 Thousand USD | -9172907.609% |
| ConvaTec Group Plc | 395.54 Million USD | -1058.161% |
| ConvaTec Group Plc | 396.1 Million USD | -1056.526% |
| Encision Inc. | 1.4 Million USD | -326568.749% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 49289964.429% |
| LifePoint, Inc. | 2.3 Million USD | -198268.107% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -190536.704% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -1038675.51% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -4985642.583% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -471054.271% |
| SmileDirectClub, Inc. | 49.87 Million USD | -9085.147% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -1202.349% |
| SheerVision, Inc. | 339.66 Thousand USD | -1348589.731% |
| United Health Products, Inc. | 33.59 Thousand USD | -13634640.163% |
| Vasamed, Inc. | 449.02 Thousand USD | -1020103.64% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -53547532.963% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -1421806.864% |